A team of researchers from Taiwan, the USA, and Germany conducted a re-analysis of data obtained during clinical trials of a new experimental drug. This drug is capable of inducing apoptosis in fat cells.
According to the analysis results, it was established that the use of this drug leads to a significant reduction in the volume of visceral adipose tissue, which was confirmed by magnetic resonance imaging (MRI) methods.
The obtained data will be presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in 2026.